Simosis International

Simosis International is a biotechnology company specializing in the development of advanced transdermal drug delivery technologies. The company's proprietary Simosis (Simultaneous Osmosis) platform utilizes electro-osmotic and iontophoretic mechanisms to facilitate the non-invasive delivery of therapeutic agents through the skin. This technology is designed to enhance the delivery of both small molecules and potentially larger biologics that typically have poor skin permeability. By providing a controlled and needle-free administration route, Simosis aims to improve patient adherence and therapeutic efficacy in areas such as pain management and neurology. The company's research and development efforts are closely linked to academic innovations in pharmaceutical sciences.